Literature DB >> 21969317

Reversal of new oral anticoagulants.

Elisabeth M Battinelli.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21969317     DOI: 10.1161/CIRCULATIONAHA.111.054510

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agents.

Authors:  Sunny Patel; Dylan Steen
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

Review 2.  Emergency reversal of anticoagulation: novel agents.

Authors:  Michael Levine; Joshua N Goldstein
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

3.  Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.

Authors:  David E Haines; Michelle Mead-Salley; Miguel Salazar; Francis E Marchlinski; Erica Zado; Hugh Calkins; Hirad Yarmohammadi; Koonlawee Nademanee; Montawatt Amnueypol; Allan C Skanes; Pradyot Saklani
Journal:  J Interv Card Electrophysiol       Date:  2013-06-06       Impact factor: 1.900

4.  Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.

Authors:  Tripti Singh; Thin Thin Maw; Brian L Henry; Núria M Pastor-Soler; Mark L Unruh; Kenneth R Hallows; Thomas D Nolin
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

Review 5.  Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies.

Authors:  Arne Lauer; Waltraud Pfeilschifter; Chris B Schaffer; Eng H Lo; Christian Foerch
Journal:  Lancet Neurol       Date:  2013-03-18       Impact factor: 44.182

6.  A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin.

Authors:  Bruce S Stambler
Journal:  Int Arch Med       Date:  2013-10-31

7.  Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function.

Authors:  Thin Thin Maw; Brian L Henry; Tripti Singh
Journal:  Clin Nephrol Case Stud       Date:  2014-08-20

Review 8.  Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.

Authors:  Caleb Ferguson; Sally C Inglis; Phillip J Newton; Sandy Middleton; Peter S Macdonald; Patricia M Davidson
Journal:  Vasc Health Risk Manag       Date:  2013-01-16

9.  Management of anticoagulation in hip fractures: A pragmatic approach.

Authors:  Rafik Yassa; Mahdi Yacine Khalfaoui; Ihab Hujazi; Hannah Sevenoaks; Paul Dunkow
Journal:  EFORT Open Rev       Date:  2017-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.